metadata
base_model: mixedbread-ai/deepset-mxbai-embed-de-large-v1
library_name: sentence-transformers
metrics:
- cosine_accuracy@1
- cosine_accuracy@3
- cosine_accuracy@5
- cosine_accuracy@10
- cosine_precision@1
- cosine_precision@3
- cosine_precision@5
- cosine_precision@10
- cosine_recall@1
- cosine_recall@3
- cosine_recall@5
- cosine_recall@10
- cosine_ndcg@10
- cosine_mrr@10
- cosine_map@100
pipeline_tag: sentence-similarity
tags:
- sentence-transformers
- sentence-similarity
- feature-extraction
- generated_from_trainer
- dataset_size:1814
- loss:MatryoshkaLoss
- loss:MultipleNegativesRankingLoss
widget:
- source_sentence: >-
The document you provided seems to be a list of compounds, some of which
are well-known drugs or drugs used in experimental contexts, and others
that don't appear to have recognized applications in medicine or science.
The list includes substances like cortisol, a hormone, and filopram, which
is related to anesthetics or possibly a misprint or misclassification. The
side effects listed are also a mix, with some being plausible reactions to
certain medication (like Edema, dysphagia) and others being quite unusual
for commonly recognized drug interactions (like retinal vein occlusion,
which is not a typical side effect of most medications).
It would be useful to have labels or references indicating which of these
compounds are actually drugs and which are other chemical substances. For
instance, cortisol, if given its correct context, would typically have
side effects associated with cortisol therapy such as fluid retention or
electrolyte imbalances.
If you need detailed information on how these substances work or what
their possible side effects might be, you'll likely need to refer to a
medical compendium or a pharmacology resource for accurate data. It's also
important to clarify the intended use for this list, whether for
educational purposes, research, or another context; the provided list
appears to be a jumbled amalgamation, which might not have clear clinical
relevance without additional detail.
sentences:
- >-
Can you suggest medications targeting the GC gene/protein with a proven
synergy with AVE9633?
- >-
Could you help identify the gene or protein that facilitates
sodium-dependent transportation and elimination of organic anions, with
a particular emphasis on those implicated in the cellular efflux of
potentially hazardous organic anions? Additionally, I'm interested in
understanding if this gene or protein also mediates the transport of
drugs known to exhibit synergistic pharmacological interactions with
Ractopamine.
- >-
Can you list the medications suitable for benign prostatic hyperplasia
and tell me if any are linked to dysphagia as a side effect?
- source_sentence: >-
The provided information describes a gene that plays a role in multiple
biological processes and is linked with certain diseases. Here
sentences:
- >-
Which genes or proteins interact with the "Regulation of HSF1-mediated
heat shock response" pathway and also engage in protein-protein
interactions with PRNP?
- >-
Which anatomical parts lack the expression of genes or proteins involved
in the L-alanine degradation pathway?
- >-
What is the name of a disease classified as a variant or subtype of
sinoatrial node disease in the latest medical disease taxonomy?
- source_sentence: >-
The list you've provided contains a variety of medications, including
antidepressants, antihistamines, anxiolytics, and more. Here's a breakdown
by category:
### Antidepressants
- **Amphetamine**
- **Cevimeline**
- **Esmolol**
- **Bortezomib**
- **
sentences:
- >-
What are some related conditions to triple-negative breast cancer that
could be causing persistent fatigue?
- >-
Which medication is effective against simple Plasmodium falciparum
infections and functions by engaging with genes or proteins that
interact with the minor groove of DNA rich in adenine and thymine?
- >-
Which diseases associated with SRSF2 gene mutations are primarily found
in adults and the elderly?
- source_sentence: >-
The drug mentioned in the query is "Dabigatran". It belongs to the class
of drugs known as direct thrombin inhibitors. This class of drugs is used
primarily for the prevention and treatment of thromboembolic disorders.
Regarding potential side effects, they include:
1. Inflammatory abnormality of the skin (Erythema)
2. Hemolytic anemia (a type of anemia where red blood cells are destroyed
prematurely)
3. Thrombocytopenia (low platelet count)
4. Pancytopenia (a decrease in the number of all types of blood cells -
red, white, and platelet cells)
5. Fever
6. Pain
7. Seizure
8. Headache
9. Vomiting
10. Abdominal pain
11. Hyperactivity
12. Erythroderma (a type of skin flare characterized by a redness over the
trunk and limbs)
13. Vertigo (a sensation of spinning or motion)
14. Granulocytopenia (low neutrophil count)
15. Pruritus (severe itching)
16. Confusion
17. Eosinophilia (a condition characterized by an increased number of
eosinophils, a type of white blood cell)
18. Anaphylactic shock (a serious allergic reaction)
19. Hyperkinetic movements
20. Nausea
21. Acute sinusitis (inflammation of the sinus cavities)
22. Agitation
23. Excessive daytime somnolence (excessively sleepy during the day)
24. Aplastic anemia (a condition where the bone marrow fails to produce
enough new blood cells)
25. Increased blood urea nitrogen (BUN) (a marker of kidney function,
indicating the kidneys are not working properly)
26. Prolonged prothrombin time (an indication of an increased risk of
bleeding, due to a reduction in clotting protein)
27. Recurrent tonsillitis (repeated inflammation of the tonsils)
Dabigatran works by inhibiting thrombin (Factor IIa), an enzyme involved
in the clotting process. If any of these side effects are experienced, it
is important to seek medical attention or consult with a healthcare
provider.
sentences:
- >-
What are the clinical manifestations or phenotypic characteristics
associated with the subtype of myocardial infarction known as
posteroinferior?
- >-
Could you supply a list of drugs prescribed for respiratory infections
that may also lead to side effects like hemolytic anemia and nausea?
- >-
Which diseases are associated with the FAM111A gene that present with
both skeletal and endocrine system abnormalities?
- source_sentence: >-
The list you provided seems to be a mix of various chemical substances,
some of which appear to be medications, others are chemical compounds, and
a few could be substances from other fields (e.g., water treatment, food
additives). To be more precise, it would be helpful to categorize them
properly based on their common usage:
### Medications and Drugs:
- **Antibiotics**: Cefoxitin, Tobramycin, Amikacin
- ** pain and inflammation relievers**: Benoxaprofen, Daptomycin,
Ceftolozane, Salicylates (Benzydamine, Dexamethasone sodium phosphate)
- **Intravenous fluids**: Magnesium trisilicate
- **Antivirals**: Ribavirin, Inotersen
- **Antibacterial agents**: Epirizole, Floctafenine, Flunixin
- **Vaccines**: Vaborbactam, Brincidofovir, Adefovir
- **Neuromodulators**: Cefatrizine, Bumadizone, Alminoprofen
- **Cancer treatments**: Colistin, Nitrofurantoin, Sisomicin
### Chemical Compounds:
- **Salts and salts of acidity**: Fosfomycin, Azosemide, Mofebutazone
- **Amino acids**: Phenylalanine, Nitrosalicylic
sentences:
- >-
Is there a regulatory function associated with the epidermal growth
factor receptor or its interacting proteins in the control of genes or
proteins that participate in the inactivation of fast sodium channels
during Phase 1 of cardiac action potential propagation?
- >-
Which diseases, either as subtypes or complications, should be
considered when a patient shows symptoms suggesting neoplastic
syndromes?
- Which drugs interact with the SERPINA1 gene/protein as carriers?
model-index:
- name: SentenceTransformer based on mixedbread-ai/deepset-mxbai-embed-de-large-v1
results:
- task:
type: information-retrieval
name: Information Retrieval
dataset:
name: dim 768
type: dim_768
metrics:
- type: cosine_accuracy@1
value: 0.3910891089108911
name: Cosine Accuracy@1
- type: cosine_accuracy@3
value: 0.4752475247524752
name: Cosine Accuracy@3
- type: cosine_accuracy@5
value: 0.49504950495049505
name: Cosine Accuracy@5
- type: cosine_accuracy@10
value: 0.5544554455445545
name: Cosine Accuracy@10
- type: cosine_precision@1
value: 0.3910891089108911
name: Cosine Precision@1
- type: cosine_precision@3
value: 0.15841584158415842
name: Cosine Precision@3
- type: cosine_precision@5
value: 0.09900990099009901
name: Cosine Precision@5
- type: cosine_precision@10
value: 0.05544554455445544
name: Cosine Precision@10
- type: cosine_recall@1
value: 0.3910891089108911
name: Cosine Recall@1
- type: cosine_recall@3
value: 0.4752475247524752
name: Cosine Recall@3
- type: cosine_recall@5
value: 0.49504950495049505
name: Cosine Recall@5
- type: cosine_recall@10
value: 0.5544554455445545
name: Cosine Recall@10
- type: cosine_ndcg@10
value: 0.4669635292605997
name: Cosine Ndcg@10
- type: cosine_mrr@10
value: 0.439788621719315
name: Cosine Mrr@10
- type: cosine_map@100
value: 0.44615433269461197
name: Cosine Map@100
SentenceTransformer based on mixedbread-ai/deepset-mxbai-embed-de-large-v1
This is a sentence-transformers model finetuned from mixedbread-ai/deepset-mxbai-embed-de-large-v1 on the json dataset. It maps sentences & paragraphs to a 1024-dimensional dense vector space and can be used for semantic textual similarity, semantic search, paraphrase mining, text classification, clustering, and more.
Model Details
Model Description
- Model Type: Sentence Transformer
- Base model: mixedbread-ai/deepset-mxbai-embed-de-large-v1
- Maximum Sequence Length: 512 tokens
- Output Dimensionality: 1024 tokens
- Similarity Function: Cosine Similarity
- Training Dataset:
- json
Model Sources
- Documentation: Sentence Transformers Documentation
- Repository: Sentence Transformers on GitHub
- Hugging Face: Sentence Transformers on Hugging Face
Full Model Architecture
SentenceTransformer(
(0): Transformer({'max_seq_length': 512, 'do_lower_case': False}) with Transformer model: XLMRobertaModel
(1): Pooling({'word_embedding_dimension': 1024, 'pooling_mode_cls_token': False, 'pooling_mode_mean_tokens': True, 'pooling_mode_max_tokens': False, 'pooling_mode_mean_sqrt_len_tokens': False, 'pooling_mode_weightedmean_tokens': False, 'pooling_mode_lasttoken': False, 'include_prompt': True})
(2): Normalize()
)
Usage
Direct Usage (Sentence Transformers)
First install the Sentence Transformers library:
pip install -U sentence-transformers
Then you can load this model and run inference.
from sentence_transformers import SentenceTransformer
# Download from the 🤗 Hub
model = SentenceTransformer("FareedKhan/mixedbread-ai_deepset-mxbai-embed-de-large-v1_FareedKhan_prime_synthetic_data_2k_3_8")
# Run inference
sentences = [
'\nThe list you provided seems to be a mix of various chemical substances, some of which appear to be medications, others are chemical compounds, and a few could be substances from other fields (e.g., water treatment, food additives). To be more precise, it would be helpful to categorize them properly based on their common usage:\n\n### Medications and Drugs:\n- **Antibiotics**: Cefoxitin, Tobramycin, Amikacin\n- ** pain and inflammation relievers**: Benoxaprofen, Daptomycin, Ceftolozane, Salicylates (Benzydamine, Dexamethasone sodium phosphate)\n- **Intravenous fluids**: Magnesium trisilicate\n- **Antivirals**: Ribavirin, Inotersen\n- **Antibacterial agents**: Epirizole, Floctafenine, Flunixin\n- **Vaccines**: Vaborbactam, Brincidofovir, Adefovir\n- **Neuromodulators**: Cefatrizine, Bumadizone, Alminoprofen\n- **Cancer treatments**: Colistin, Nitrofurantoin, Sisomicin\n\n### Chemical Compounds:\n- **Salts and salts of acidity**: Fosfomycin, Azosemide, Mofebutazone\n- **Amino acids**: Phenylalanine, Nitrosalicylic',
'Which drugs interact with the SERPINA1 gene/protein as carriers?',
'Is there a regulatory function associated with the epidermal growth factor receptor or its interacting proteins in the control of genes or proteins that participate in the inactivation of fast sodium channels during Phase 1 of cardiac action potential propagation?',
]
embeddings = model.encode(sentences)
print(embeddings.shape)
# [3, 1024]
# Get the similarity scores for the embeddings
similarities = model.similarity(embeddings, embeddings)
print(similarities.shape)
# [3, 3]
Evaluation
Metrics
Information Retrieval
- Dataset:
dim_768
- Evaluated with
InformationRetrievalEvaluator
Metric | Value |
---|---|
cosine_accuracy@1 | 0.3911 |
cosine_accuracy@3 | 0.4752 |
cosine_accuracy@5 | 0.495 |
cosine_accuracy@10 | 0.5545 |
cosine_precision@1 | 0.3911 |
cosine_precision@3 | 0.1584 |
cosine_precision@5 | 0.099 |
cosine_precision@10 | 0.0554 |
cosine_recall@1 | 0.3911 |
cosine_recall@3 | 0.4752 |
cosine_recall@5 | 0.495 |
cosine_recall@10 | 0.5545 |
cosine_ndcg@10 | 0.467 |
cosine_mrr@10 | 0.4398 |
cosine_map@100 | 0.4462 |
Training Details
Training Dataset
json
- Dataset: json
- Size: 1,814 training samples
- Columns:
positive
andanchor
- Approximate statistics based on the first 1000 samples:
positive anchor type string string details - min: 3 tokens
- mean: 267.06 tokens
- max: 512 tokens
- min: 15 tokens
- mean: 39.66 tokens
- max: 120 tokens
- Samples:
positive anchor
Based on the provided information, it appears you are describing a complex biological system involving various molecules, drugs, diseases, and anatomical structures. Here's a breakdown:
### Key Entities
1. Molecules and Targets
- Mentioned molecules include metabolites, phenols, and drugs, with specific functional groups related to their chemical properties.
- Targets include enzymes (like acetyl-CoA carboxylase) and diseases causing various health conditions (e.g., Finnish type amyloidosis, lung cancer).
2. Functionality and Interactions
- The molecules and drugs interact with various biological processes, pathways, and bodily systems.Identify common genetic targets that interact with both N-(3,5-dibromo-4-hydroxyphenyl)benzamide and 1-Naphthylamine-5-sulfonic acid.
The provided list appears to be a collection of gene symbols related to cancer. Gene symbols are used in genetics and molecular biology to identify genes. Each symbol is associated with a specific gene that plays a role in cellular functions, including cancer processes. When studying cancer, researchers often analyze these genes to understand their roles in tumor development, potential as targets for therapy, or as indicators for patient prognosis. For example, some genes listed are known oncogenes or tumor suppressor genes:
- TP53: A tumor suppressor gene that when mutated can lead to uncontrolled cell growth.
- P53, POLD1, PTEN: These are well-known tumor suppressors that help regulate cell division and DNA repair.
- BRCAWhich anatomical structures lack expression of genes or proteins involved in the homogentisate degradation pathway?
The gene in question appears to have a wide range of functions across various biological processes and body systems. It's involved in several key areas that regulate cellular responses, metabolic processes, and organ development. Here is a summary of its potential roles:
1. Cell Growth and Regulation: The gene contributes to growth control in cells, particularly in smooth muscle cells, and seems to influence cell proliferation, which is essential for tissue repair and development.
2. Nerve Function: It plays a role in functions like signal transduction, neurotrophin signaling, and regulation of neural activity, suggesting it’s involved in neural health and development.
3. Metabolic Processes: There is evidence linkingIdentify genes or proteins that interact with angiotensin-converting enzyme 2 (ACE2) and are linked to a common phenotype or effect.
- Loss:
MatryoshkaLoss
with these parameters:{ "loss": "MultipleNegativesRankingLoss", "matryoshka_dims": [ 768 ], "matryoshka_weights": [ 1 ], "n_dims_per_step": -1 }
Training Hyperparameters
Non-Default Hyperparameters
eval_strategy
: epochlearning_rate
: 1e-05warmup_ratio
: 0.1bf16
: Truetf32
: Falseload_best_model_at_end
: True
All Hyperparameters
Click to expand
overwrite_output_dir
: Falsedo_predict
: Falseeval_strategy
: epochprediction_loss_only
: Trueper_device_train_batch_size
: 8per_device_eval_batch_size
: 8per_gpu_train_batch_size
: Noneper_gpu_eval_batch_size
: Nonegradient_accumulation_steps
: 1eval_accumulation_steps
: Nonetorch_empty_cache_steps
: Nonelearning_rate
: 1e-05weight_decay
: 0.0adam_beta1
: 0.9adam_beta2
: 0.999adam_epsilon
: 1e-08max_grad_norm
: 1.0num_train_epochs
: 3max_steps
: -1lr_scheduler_type
: linearlr_scheduler_kwargs
: {}warmup_ratio
: 0.1warmup_steps
: 0log_level
: passivelog_level_replica
: warninglog_on_each_node
: Truelogging_nan_inf_filter
: Truesave_safetensors
: Truesave_on_each_node
: Falsesave_only_model
: Falserestore_callback_states_from_checkpoint
: Falseno_cuda
: Falseuse_cpu
: Falseuse_mps_device
: Falseseed
: 42data_seed
: Nonejit_mode_eval
: Falseuse_ipex
: Falsebf16
: Truefp16
: Falsefp16_opt_level
: O1half_precision_backend
: autobf16_full_eval
: Falsefp16_full_eval
: Falsetf32
: Falselocal_rank
: 0ddp_backend
: Nonetpu_num_cores
: Nonetpu_metrics_debug
: Falsedebug
: []dataloader_drop_last
: Falsedataloader_num_workers
: 0dataloader_prefetch_factor
: Nonepast_index
: -1disable_tqdm
: Falseremove_unused_columns
: Truelabel_names
: Noneload_best_model_at_end
: Trueignore_data_skip
: Falsefsdp
: []fsdp_min_num_params
: 0fsdp_config
: {'min_num_params': 0, 'xla': False, 'xla_fsdp_v2': False, 'xla_fsdp_grad_ckpt': False}fsdp_transformer_layer_cls_to_wrap
: Noneaccelerator_config
: {'split_batches': False, 'dispatch_batches': None, 'even_batches': True, 'use_seedable_sampler': True, 'non_blocking': False, 'gradient_accumulation_kwargs': None}deepspeed
: Nonelabel_smoothing_factor
: 0.0optim
: adamw_torchoptim_args
: Noneadafactor
: Falsegroup_by_length
: Falselength_column_name
: lengthddp_find_unused_parameters
: Noneddp_bucket_cap_mb
: Noneddp_broadcast_buffers
: Falsedataloader_pin_memory
: Truedataloader_persistent_workers
: Falseskip_memory_metrics
: Trueuse_legacy_prediction_loop
: Falsepush_to_hub
: Falseresume_from_checkpoint
: Nonehub_model_id
: Nonehub_strategy
: every_savehub_private_repo
: Falsehub_always_push
: Falsegradient_checkpointing
: Falsegradient_checkpointing_kwargs
: Noneinclude_inputs_for_metrics
: Falseeval_do_concat_batches
: Truefp16_backend
: autopush_to_hub_model_id
: Nonepush_to_hub_organization
: Nonemp_parameters
:auto_find_batch_size
: Falsefull_determinism
: Falsetorchdynamo
: Noneray_scope
: lastddp_timeout
: 1800torch_compile
: Falsetorch_compile_backend
: Nonetorch_compile_mode
: Nonedispatch_batches
: Nonesplit_batches
: Noneinclude_tokens_per_second
: Falseinclude_num_input_tokens_seen
: Falseneftune_noise_alpha
: Noneoptim_target_modules
: Nonebatch_eval_metrics
: Falseeval_on_start
: Falseuse_liger_kernel
: Falseeval_use_gather_object
: Falsebatch_sampler
: batch_samplermulti_dataset_batch_sampler
: proportional
Training Logs
Epoch | Step | Training Loss | dim_768_cosine_map@100 |
---|---|---|---|
0 | 0 | - | 0.3930 |
0.0441 | 10 | 1.18 | - |
0.0881 | 20 | 1.0507 | - |
0.1322 | 30 | 0.9049 | - |
0.1762 | 40 | 0.8999 | - |
0.2203 | 50 | 0.6519 | - |
0.2643 | 60 | 0.5479 | - |
0.3084 | 70 | 0.6493 | - |
0.3524 | 80 | 0.4706 | - |
0.3965 | 90 | 0.5459 | - |
0.4405 | 100 | 0.5692 | - |
0.4846 | 110 | 0.7834 | - |
0.5286 | 120 | 0.5341 | - |
0.5727 | 130 | 0.5343 | - |
0.6167 | 140 | 0.4865 | - |
0.6608 | 150 | 0.3942 | - |
0.7048 | 160 | 0.3578 | - |
0.7489 | 170 | 0.5158 | - |
0.7930 | 180 | 0.3426 | - |
0.8370 | 190 | 0.5789 | - |
0.8811 | 200 | 0.5271 | - |
0.9251 | 210 | 0.577 | - |
0.9692 | 220 | 0.5193 | - |
1.0 | 227 | - | 0.4354 |
1.0132 | 230 | 0.4598 | - |
1.0573 | 240 | 0.2735 | - |
1.1013 | 250 | 0.2919 | - |
1.1454 | 260 | 0.3206 | - |
1.1894 | 270 | 0.2851 | - |
1.2335 | 280 | 0.3899 | - |
1.2775 | 290 | 0.3279 | - |
1.3216 | 300 | 0.2155 | - |
1.3656 | 310 | 0.3471 | - |
1.4097 | 320 | 0.327 | - |
1.4537 | 330 | 0.229 | - |
1.4978 | 340 | 0.2902 | - |
1.5419 | 350 | 0.3216 | - |
1.5859 | 360 | 0.2902 | - |
1.6300 | 370 | 0.4527 | - |
1.6740 | 380 | 0.1583 | - |
1.7181 | 390 | 0.3144 | - |
1.7621 | 400 | 0.2573 | - |
1.8062 | 410 | 0.2309 | - |
1.8502 | 420 | 0.3475 | - |
1.8943 | 430 | 0.3082 | - |
1.9383 | 440 | 0.3176 | - |
1.9824 | 450 | 0.2104 | - |
2.0 | 454 | - | 0.4453 |
2.0264 | 460 | 0.2615 | - |
2.0705 | 470 | 0.1599 | - |
2.1145 | 480 | 0.1015 | - |
2.1586 | 490 | 0.2154 | - |
2.2026 | 500 | 0.1161 | - |
2.2467 | 510 | 0.2208 | - |
2.2907 | 520 | 0.2035 | - |
2.3348 | 530 | 0.1622 | - |
2.3789 | 540 | 0.1758 | - |
2.4229 | 550 | 0.2782 | - |
2.4670 | 560 | 0.303 | - |
2.5110 | 570 | 0.1787 | - |
2.5551 | 580 | 0.2221 | - |
2.5991 | 590 | 0.1686 | - |
2.6432 | 600 | 0.2522 | - |
2.6872 | 610 | 0.1334 | - |
2.7313 | 620 | 0.1102 | - |
2.7753 | 630 | 0.2499 | - |
2.8194 | 640 | 0.2648 | - |
2.8634 | 650 | 0.1859 | - |
2.9075 | 660 | 0.2385 | - |
2.9515 | 670 | 0.2283 | - |
2.9956 | 680 | 0.1126 | - |
3.0 | 681 | - | 0.4462 |
- The bold row denotes the saved checkpoint.
Framework Versions
- Python: 3.10.10
- Sentence Transformers: 3.1.1
- Transformers: 4.45.1
- PyTorch: 2.2.1+cu121
- Accelerate: 0.34.2
- Datasets: 3.0.1
- Tokenizers: 0.20.0
Citation
BibTeX
Sentence Transformers
@inproceedings{reimers-2019-sentence-bert,
title = "Sentence-BERT: Sentence Embeddings using Siamese BERT-Networks",
author = "Reimers, Nils and Gurevych, Iryna",
booktitle = "Proceedings of the 2019 Conference on Empirical Methods in Natural Language Processing",
month = "11",
year = "2019",
publisher = "Association for Computational Linguistics",
url = "https://arxiv.org/abs/1908.10084",
}
MatryoshkaLoss
@misc{kusupati2024matryoshka,
title={Matryoshka Representation Learning},
author={Aditya Kusupati and Gantavya Bhatt and Aniket Rege and Matthew Wallingford and Aditya Sinha and Vivek Ramanujan and William Howard-Snyder and Kaifeng Chen and Sham Kakade and Prateek Jain and Ali Farhadi},
year={2024},
eprint={2205.13147},
archivePrefix={arXiv},
primaryClass={cs.LG}
}
MultipleNegativesRankingLoss
@misc{henderson2017efficient,
title={Efficient Natural Language Response Suggestion for Smart Reply},
author={Matthew Henderson and Rami Al-Rfou and Brian Strope and Yun-hsuan Sung and Laszlo Lukacs and Ruiqi Guo and Sanjiv Kumar and Balint Miklos and Ray Kurzweil},
year={2017},
eprint={1705.00652},
archivePrefix={arXiv},
primaryClass={cs.CL}
}